ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes

ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes

The development of new substances with the ability to interact with a biological target is only the first stage in the process of the creation of new drugs. The 5-nitroisatin derivatives considered in this study are new inhibitors of cyclin-dependent kinase 2 (CDK2) intended for anticancer therapy....

Full description

Bibliographic Details
Main Authors: Przemysław Czeleń, Tomasz Jeliński, Agnieszka Skotnicka, Beata Szefler, Kamil Szupryczyński
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
isatin
CDK2
competitive inhibition
ADMET
solubility
cosolvation
Online Access:https://www.mdpi.com/2227-9059/11/11/3019

Similar Items

Similar Items